Prostate cancer and prostatic diseases
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer.
Xiaolei Shi, Jarey H Wang, Brian F Chapin, Ana Aparicio, Sumit K Subudhi, Phuoc T Tran, Ryan J Park, Matthew P Deek, Hong Zhang, Kevin C Bylund, Micheal Cummings, Andrew J Armstrong, Chad Tang, Philip Sutera
Published: 202510.1038/s41391-025-01041-z
Abstract
BACKGROUND: Oligometastatic hormone-sensitive prostate cancer (omHSPC) represents a favorable and potentially curable disease state in which metastasis-directed therapy (MDT) improves outcomes. The combination of MDT and systemic treatment is the nex…
Preview only. Read the full abstract at the source